Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

26.79 -0.07 (-0.26%)

Delayed Quote Updated: 3:07 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

(VKTX) - Analyzing Viking Therapeutics's Short Interest ↗

February 20, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

February 19, 2024

Via Benzinga

The 3 Biotech Stocks That Could Make Your February Unforgettable ↗

February 15, 2024

After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.

Via InvestorPlace

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution ↗

February 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.

Via InvestorPlace

Amazon, Progress Software And 2 Other Stocks Insiders Are Selling ↗

February 12, 2024

The Nasdaq 100 closed higher by 1% on Friday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Recap: Viking Therapeutics Q4 Earnings ↗

February 07, 2024

Via Benzinga

Earnings Scheduled For February 7, 2024 ↗

February 07, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.

Via Benzinga

Earnings Preview: Viking Therapeutics ↗

February 06, 2024

Via Benzinga

1 Under-the-Radar Stock That Could Triple By 2030 ↗

November 04, 2023

This small-cap biotech stock is going to compete against some giants.

Via The Motley Fool

The 3 Most Undervalued Biotech Stocks to Buy in February 2024 ↗

February 08, 2024

With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.

Via InvestorPlace

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 08, 2024

Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

Via Benzinga

Earnings Scheduled For October 25, 2023 ↗

October 25, 2023

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.

Via Benzinga

Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug ↗

February 08, 2024

The company is looking to take on Eli Lilly's tirzepatide as both a shot and a pill for weight loss.

Via Investor's Business Daily

Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday ↗

February 08, 2024

U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday.

Via Benzinga

Topics Stocks

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024 ↗

February 02, 2024

These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns

Via InvestorPlace

2 Rising Biotechs That Could Become the Next Novo Nordisk ↗

January 29, 2024

Each of these companies has a big market in its sights.

Via The Motley Fool

3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024 ↗

January 22, 2024

Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune.

Via InvestorPlace

2 Stocks That Could Soar This Year: Are They Buys? ↗

January 22, 2024

They might perform well in 2024, but how will they do beyond that?

Via The Motley Fool

2 biotechs with promising weight-loss drugs coming

January 16, 2024

Clinical weight-loss medications have been making headlines as GLP-1 drugs like Novo Nordisk A/S (NYSE: NVO) owned Ozempic and Wegovy and Eli Lilly and Co.

Via MarketBeat

The 3 Best Biotech Stocks to Buy in January 2024 ↗

January 09, 2024

Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

January 09, 2024

Via Benzinga

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 ↗

January 02, 2024

Lower interest rates and the low valuation of many biotech stocks are likely to result in many drug maker stocks being acquired in 2024.

Via InvestorPlace

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? ↗

December 12, 2023

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.

Via The Motley Fool

Why Viking Therapeutics Was Crushing It This Week ↗

December 08, 2023

Nowadays, it's good to be a developer of next-generation weight loss drugs.

Via The Motley Fool

What's Going On With Viking Therapeutics Shares Tuesday? ↗

November 14, 2023

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b study

Via Benzinga

Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders

October 19, 2023

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END

Via FinancialNewsMedia

Why Are Stocks Down Today? ↗

October 18, 2023

Stocks are down again on Wednesday as investors continue to feel the effects of several major catalysts hitting the market.

Via InvestorPlace

Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts ↗

October 18, 2023

Pfizer layoffs are a hot topic among PFE stock traders on Wednesday as they pour over the details of the job cuts amid a Covid slump.

Via InvestorPlace

Topics Workforce

Why Is Viking Therapeutics (VKTX) Stock Moving Today? ↗

October 18, 2023

Viking Therapeutics stock is on the move Wednesday as investors react to results from the company's latest clinical trial!

Via InvestorPlace

Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 18, 2023

Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court...

Via Benzinga

Topics Bankruptcy

< Previous 1 2

...

28 29 30 31 32 33 34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.